β-Blockers: No longer an option for uncomplicated hypertension
Authors:
- Sripal BangaloreSBSripal Bangalore
- Gayathri KamalakkannanGKGayathri Kamalakkannan
- Franz H. MesserliFMFranz H. Messerli
- 1 July 2008
- journal article
- research article
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 2 (4) , 280-285
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Hypertension in the elderly: a compelling contraindication for β-blockers?Journal of Human Hypertension, 2007
- How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysisJournal Of Hypertension, 2006
- Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patientsJournal Of Hypertension, 2006
- Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery?Journal Of Hypertension, 2005
- British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summaryBMJ, 2004
- Third-Generation β-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP EffluxCirculation, 2003
- Efficacy and tolerability profile of nebivolol vs atenolol in mild‐to‐moderate essential hypertension: Results of a double‐blind randomized multicentre trialBlood Pressure, 2003
- Diuretics and β-blockers: Is there a risk for dyslipidemia?American Heart Journal, 2000
- Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.BMJ, 1992
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990